<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4DF3B36B-DFC1-41F4-BA43-548C1039E933"><gtr:id>4DF3B36B-DFC1-41F4-BA43-548C1039E933</gtr:id><gtr:name>Papworth Hospital NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Papworth Everard</gtr:line1><gtr:city>Cambridge</gtr:city><gtr:postCode>CB23 3RE</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DD21B8FC-26A6-4A3A-9A23-207B6667CB41"><gtr:id>DD21B8FC-26A6-4A3A-9A23-207B6667CB41</gtr:id><gtr:name>University of Pittsburgh</gtr:name><gtr:address><gtr:line1>University of Pittsburgh</gtr:line1><gtr:line4>Pittsburgh</gtr:line4><gtr:line5>Pennsylvania</gtr:line5><gtr:postCode>PA 15260</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/468F2797-5295-4912-BDED-8F3402CE246A"><gtr:id>468F2797-5295-4912-BDED-8F3402CE246A</gtr:id><gtr:name>New York University</gtr:name><gtr:address><gtr:line1>7 East 12th Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Cambridge Institute for Medical Research</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4DF3B36B-DFC1-41F4-BA43-548C1039E933"><gtr:id>4DF3B36B-DFC1-41F4-BA43-548C1039E933</gtr:id><gtr:name>Papworth Hospital NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Papworth Everard</gtr:line1><gtr:city>Cambridge</gtr:city><gtr:postCode>CB23 3RE</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DD21B8FC-26A6-4A3A-9A23-207B6667CB41"><gtr:id>DD21B8FC-26A6-4A3A-9A23-207B6667CB41</gtr:id><gtr:name>University of Pittsburgh</gtr:name><gtr:address><gtr:line1>University of Pittsburgh</gtr:line1><gtr:line4>Pittsburgh</gtr:line4><gtr:line5>Pennsylvania</gtr:line5><gtr:postCode>PA 15260</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/468F2797-5295-4912-BDED-8F3402CE246A"><gtr:id>468F2797-5295-4912-BDED-8F3402CE246A</gtr:id><gtr:name>New York University</gtr:name><gtr:address><gtr:line1>7 East 12th Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/30F28E2C-C320-48F9-AB93-2000991D4177"><gtr:id>30F28E2C-C320-48F9-AB93-2000991D4177</gtr:id><gtr:firstName>Stefan</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>Marciniak</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601840"><gtr:id>8CE87E36-5472-4CB4-B3CE-932248F8466A</gtr:id><gtr:title>THE ROLE OF ENDOPLASMIC RETICULUM PROTEIN MISFOLDING IN CELL DEATH AND DISEASE</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0601840</gtr:grantReference><gtr:abstractText>In many human diseases defective proteins are made that damage the cell, so-called protein misfolding. In response to this, our cells reduce the rate at which they make new proteins in order to allow correction or destruction of these abnormal components. When the defect is corrected, protein synthesis increases once again. 

The reduction of protein synthesis requires a protein called PERK, while the recovery involves a protein called GADD34. We have previously shown how mutations in the GADD34 gene protect against kidney damage in an animal model of protein misfolding. This led us to hypothesise that by developing drugs either to block GADD34 function or activate PERK, we might be able to protect tissues in diseases where protein misfolding is important, such as diabetes and stroke. 

To help us identify potential drug targets, we are now studying how GADD34 and PERK are controlled by other components of the cell. We are using two main approaches: First, by studying how GADD34 and PERK are regulated in cultured human and mouse cells; and second, using genetically modified fruit flies (Drosophila melanogaster) to allow rapid identification of genes involved in the this system.</gtr:abstractText><gtr:technicalSummary>Protein mis-folding in the endoplasmic reticulum (ER) is central to the pathogenesis of many human diseases (Marciniak &amp;amp; Ron, 2006 Physiol. Rev. 86:1133). Increased protein flux through the ER (ER stress) activates mechanisms that balance protein-folding capacity with protein load. These are referred to as the unfolded protein response (UPR). The UPR combines inhibition of protein translation with a transcriptional increase of ER chaperones. Translational inhibition follows phosphorylation of eIF2 by the ER stress-sensing kinase PERK; subsequent up-regulation of GADD34, an eIF2 phosphatase, reverses this inhibition. My previous studies into ER stress-induced cell death revealed an unexpected link between GADD34-dependent recovery of protein synthesis and the causation of tissue damage (Marciniak et al., 2004 Genes Dev. 18:3066). This suggested that inhibition of GADD34 or augmenting PERK activity might protect against ER stress-induced cell death in human disease. 

Aims: 1. To characterise the post-translational modulation of PERK and GADD34 in order to identify novel factors that regulate the UPR.
2. To use Drosophila models to identify pathways linking ER stress and cell death. 

Methods: 1. I will use techniques that I have previously developed (Marciniak et al., 2006 J Cell Biol. 172: 201) to study the PERK-inactivating factors in cell lysates. In particular I will use specific phosphatase inhibitors to determine pharmacologically the class(es) of phosphatase involved. I will over-express and knockdown individual phosphatase catalytic subunits in cultured 293T cells and assess the effect on PERK phosphatase activity. The effects of cellular stresses on PERK-inactivating activity will be studied. Biochemical fractionation will be used to isolate for identification the PERK-inactivating factors involved. Using a highly sensitive assay I have developed to measure eIF2 phosphatase activity, I will study the effects of GADD34 phosphorylation on its activity, both by in vitro phosphorylation and dephosphorylation of recombinant GADD34/PP1 holoenzyme. The effect of candidate GADD34-interactors will similarly be assessed. 2. I have generated Drosophila models of PERK/GADD34 signalling. Flies expressing PERK in the eye show a dramatic atrophic eye phenotype that is dependent on PERK catalytic activity and is rescued by co-expression of GADD34. Using these flies I will test candidate PERK and GADD34-modifying genes. Also, by crossing these flies with an existing 3000 fly P-element library I will screen for novel PERK and GADD34-interacting genes. Pathways involved will be manipulated using genetic and pharmacological tools in order to dissect their involvement in cellular survival and death during protein aggregation within the ER.</gtr:technicalSummary><gtr:fund><gtr:end>2012-03-09</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-12-10</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>870482</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>New York University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Cell Biology</gtr:department><gtr:description>Drosophila cell cycle checkpoints</gtr:description><gtr:id>BB6DE45B-E5D3-4AC7-9E05-B3C7FD04C7D1</gtr:id><gtr:impact>Malzer E., Daly M.L., Moloney A., Sendall T.J., Thomas, S.L. Ryder E., Ryoo H.D., Crowther D.C., Lomas, D.A. &amp;amp; Marciniak S.J. (2010). Impaired tissue growth is mediated by checkpoint kinase 1 (CHK1) in the integrated stress response. J. Cell Sci. 123: 2892-2900.</gtr:impact><gtr:outcomeId>q2iV5frQTDH-1</gtr:outcomeId><gtr:partnerContribution>The collaborator's lab performed cell cycle staining of Drosophila eye imaginal discs and trained my PhD student in these techniques, which are now routinely used in my lab</gtr:partnerContribution><gtr:piContribution>We generated a Drosophila model to study the effects of the kinase PERK on tissue growth. This was used to perform a genetic screen that identified grapes/CHK1 as mediating some of these effects.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cambridge Institute for Medical Research (CIMR)</gtr:department><gtr:description>Epithelial and macrophage dysfunction in alpha1-antitryspin deficiency</gtr:description><gtr:id>33B66C3B-A3F3-4DF8-8BB2-C27722C06267</gtr:id><gtr:impact>New cell lines generated and being used in this project</gtr:impact><gtr:outcomeId>NY8nJkSxfRC-1</gtr:outcomeId><gtr:partnerContribution>New shared PhD Student - Dr JD (medical doctor)</gtr:partnerContribution><gtr:piContribution>I now co-supervise JD with Prof DL in which she studies the effects of antitrypsin mutants synthesised locally within airway epithelia - both Prof DL and I help design experiments and interpret their results</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Papworth Hospital NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Mesothelioma and ER stress</gtr:description><gtr:id>242E367C-158F-4ABF-AD80-42C07360992C</gtr:id><gtr:impact>This collaboration involves clinicians (including myself), scientists (from my lab) and pathologists. We have generated a tissue microarray representing over 100 individual patients and all histological subtypes of the disease. This is to be linked with a comprehensive clinical database.</gtr:impact><gtr:outcomeId>LvBYN25wbvR-1</gtr:outcomeId><gtr:partnerContribution>Access to archived patient tissues used in generation of tissue microarray</gtr:partnerContribution><gtr:piContribution>We envisaged and generated a tissue microarray with which to determine if endoplasmic reticulum stress pathways are activated in mesothelioma tissues</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pittsburgh</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Division of Pulmonary, Allergy, and Critical Care Medicine</gtr:department><gtr:description>Surfactant C mutant models</gtr:description><gtr:id>FEE14DBE-E42F-4D80-AD44-8E9E85B4E430</gtr:id><gtr:impact>Model generated and currently being used - no publications yet</gtr:impact><gtr:outcomeId>LzSzveBkYn9-1</gtr:outcomeId><gtr:partnerContribution>In collaboration with workers at U Penn, we have generated new fly models of surfactant protein aggregation. These are being used in ongoing projects. The Beers labs provided the original human mutant constructs and advice</gtr:partnerContribution><gtr:piContribution>My group generated Drosophila model with which to study the in vivo effects of the accumulation of mutant surfactant proteins</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Hosted College Student 4-week research project</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A6899785-FD84-48AA-B5A9-EF5969874283</gtr:id><gtr:impact>A-level college students undertake a 4-week research project in my group, prepare a written research report and then present the findings in poster format at a meeting hosted by the Nuffield Foundation.

One student (from 2006) chose to continue in biomedical sciences and is currently a medical student at Oxford University. A second student (from 2008) is has been accepted to study medicine at Cambridge University. The third has a research technician post during his gap year - plans to apply to University to study natural sciences. The 2013 student is completing his A-levels and is applying to study medicine.</gtr:impact><gtr:outcomeId>4AC79DE49EA</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2008,2009,2010,2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1630935</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Senior Clinical Research Fellowship</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>A424D18A-662E-443D-81D5-E95C4799E1FC</gtr:id><gtr:outcomeId>sq4ZGQUiB4d0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>90000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Diabetes UK, PhD Studentship</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:id>52F9E341-A16E-45CB-8ADA-9DD49C5EA8ED</gtr:id><gtr:outcomeId>9A9F5FB553D0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Addenbrooke's Charity, Fellowship</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Addenbrooke's Charitable Trust (ACT)</gtr:fundingOrg><gtr:id>09AEC53A-B3D9-480B-9777-E9E1D533AEC9</gtr:id><gtr:outcomeId>F9C72FBF8EE0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>93156</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BLF Phd Studentship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>British Lung Foundation (BLF)</gtr:fundingOrg><gtr:id>EADD9503-785B-49E8-A431-5FF1CECB4129</gtr:id><gtr:outcomeId>JpTveWQxBvs0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>193232</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinical Research Training Fellowship</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>28AB9BA0-7484-4D3F-A271-87AE6CCEA455</gtr:id><gtr:outcomeId>argJ2Nkcg1d0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>118839</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BLF Project Grant</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>British Lung Foundation (BLF)</gtr:fundingOrg><gtr:id>C7A2944C-D78C-49B6-BE4C-E8D65FACB5DA</gtr:id><gtr:outcomeId>50DBCC4BDC40</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>we have generated a large tissue microarray of mesothelioma tissue from 130 individuals representing all histological subtypes. We have linked anonymised clinical data for all cases</gtr:description><gtr:id>D59780FB-51C8-4041-92E1-13DB17EC62AA</gtr:id><gtr:impact>This tissue microarray is the second largest in the world for this form of cancer and has the most comprehensive linked clinical data. Although we have not yet provided it to other groups, we are planning to do so in the near future to labs that have made requests for specific projects.</gtr:impact><gtr:outcomeId>BUjy2ggLTvV</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Mesothelioma tissue microarray</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>80224BB1-7C6F-4151-A54D-E2BB2CA2DECE</gtr:id><gtr:title>Alpha1-antitrypsin deficiency and autophagy.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b7c6bfc1bae97372046055e2e769195"><gtr:id>6b7c6bfc1bae97372046055e2e769195</gtr:id><gtr:otherNames>Marciniak SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>YG52RttzkQA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>065DDE28-E747-45CF-9718-5FDA6455E00B</gtr:id><gtr:title>The unfolded protein response in lung disease.</gtr:title><gtr:parentPublicationTitle>Proceedings of the American Thoracic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93f4df0b5ffc87c890d3d0a7ce893fed"><gtr:id>93f4df0b5ffc87c890d3d0a7ce893fed</gtr:id><gtr:otherNames>Marcinak SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1546-3222</gtr:issn><gtr:outcomeId>EaX39CT3ybm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>637B3E82-AF07-4787-8895-70250AC27477</gtr:id><gtr:title>Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4377ed4861af442d6d8939bfb897ce6"><gtr:id>a4377ed4861af442d6d8939bfb897ce6</gtr:id><gtr:otherNames>Liu B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>SBbgKMSUzzZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92ACD26E-42D8-459F-BEC5-A97487919C93</gtr:id><gtr:title>Interactions between N-linked glycosylation and polymerisation of neuroserpin within the endoplasmic reticulum.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40c739b4f07195cb05078715b6e21185"><gtr:id>40c739b4f07195cb05078715b6e21185</gtr:id><gtr:otherNames>Moriconi C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>5675ed7e10e94</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF442C73-F12B-403D-815B-8B6BF9FF1036</gtr:id><gtr:title>Function of monocytes and monocyte-derived macrophages in a1-antitrypsin deficiency.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30cd61943b2bee3fd9ce96dc8bf1fc16"><gtr:id>30cd61943b2bee3fd9ce96dc8bf1fc16</gtr:id><gtr:otherNames>Van't Wout EF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>544e5818ed2e16.76322552</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD3931B1-7B93-4DB0-9D2A-E9490C4D9B50</gtr:id><gtr:title>Modeling serpin conformational diseases in Drosophila melanogaster.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e38e486731c929953d5e646e4801bba"><gtr:id>2e38e486731c929953d5e646e4801bba</gtr:id><gtr:otherNames>Jahn TR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0076-6879</gtr:issn><gtr:outcomeId>BoB6W1q1baR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CD5F96B-E167-4D79-8D8E-81305277F3A4</gtr:id><gtr:title>a(1)-antitrypsin deficiency and inflammation.</gtr:title><gtr:parentPublicationTitle>Expert review of clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99363a5a0220904537f445b11858fb4e"><gtr:id>99363a5a0220904537f445b11858fb4e</gtr:id><gtr:otherNames>Ekeowa UI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1744-666X</gtr:issn><gtr:outcomeId>otHCT2UgcQA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6857D11-6B36-45AE-BB0A-B96AF08686EA</gtr:id><gtr:title>New Concepts in Alpha-1 Antitrypsin Deficiency Disease Mechanisms.</gtr:title><gtr:parentPublicationTitle>Annals of the American Thoracic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b7c6bfc1bae97372046055e2e769195"><gtr:id>6b7c6bfc1bae97372046055e2e769195</gtr:id><gtr:otherNames>Marciniak SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2325-6621</gtr:issn><gtr:outcomeId>58bd3c1f109ac8.81248911</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1ADAA445-175E-4800-BD8B-8F5F3FFAC031</gtr:id><gtr:title>Targeted gene correction of a1-antitrypsin deficiency in induced pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be1bae898aea75410b34af4f816f8a7a"><gtr:id>be1bae898aea75410b34af4f816f8a7a</gtr:id><gtr:otherNames>Yusa K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>A8KhAWQVd8V</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8CD4526-75B7-477E-8D31-D452A7292676</gtr:id><gtr:title>Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0396b96262cfc00bc545ab35b73fc343"><gtr:id>0396b96262cfc00bc545ab35b73fc343</gtr:id><gtr:otherNames>Rashid ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>nG12JV4NZFh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B602F4E-11CB-44AC-813C-52BF8FE99D01</gtr:id><gtr:title>Unravelling the twists and turns of the serpinopathies.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f487eaac4bf435a162a9bed8f9e60bc4"><gtr:id>f487eaac4bf435a162a9bed8f9e60bc4</gtr:id><gtr:otherNames>Roussel BD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>AoNjMTFDXc7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D81A0658-32D3-40AD-BA4C-61B2A3BF76ED</gtr:id><gtr:title>What can naturally occurring mutations tell us about the pathogenesis of COPD?</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b7c6bfc1bae97372046055e2e769195"><gtr:id>6b7c6bfc1bae97372046055e2e769195</gtr:id><gtr:otherNames>Marciniak SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>E85196C27FE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2098FC3-2224-46EC-9A7C-1F19A53F20E9</gtr:id><gtr:title>Endoplasmic reticulum polymers impair luminal protein mobility and sensitize to cellular stress in alpha1-antitrypsin deficiency.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8e91db47f6a14985649e44551f7e7f2"><gtr:id>b8e91db47f6a14985649e44551f7e7f2</gtr:id><gtr:otherNames>Ord??ez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>pm_12631_21_23197448</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41179399-27E3-43E7-8FA9-EADCEDC968A4</gtr:id><gtr:title>Palliative treatment for symptomatic malignant pericardial effusion?.</gtr:title><gtr:parentPublicationTitle>Interactive cardiovascular and thoracic surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4896432eb737cacdb634de247fdc3922"><gtr:id>4896432eb737cacdb634de247fdc3922</gtr:id><gtr:otherNames>Jama GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1569-9285</gtr:issn><gtr:outcomeId>5419da704c6ed6.71475900</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35146273-04A7-4F96-BA4F-7BD71C10DE64</gtr:id><gtr:title>A single-chain variable fragment intrabody prevents intracellular polymerization of Z a1-antitrypsin while allowing its antiproteinase activity.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8e91db47f6a14985649e44551f7e7f2"><gtr:id>b8e91db47f6a14985649e44551f7e7f2</gtr:id><gtr:otherNames>Ord??ez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>5675e0a10384e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6D95822-9274-419C-BD50-0AD53E1B92EE</gtr:id><gtr:title>Unravelling the story of protein misfolding in diabetes mellitus.</gtr:title><gtr:parentPublicationTitle>World journal of diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ce2846dbc3dd405f1e8fe7efc22c044"><gtr:id>8ce2846dbc3dd405f1e8fe7efc22c044</gtr:id><gtr:otherNames>Thomas SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1948-9358</gtr:issn><gtr:outcomeId>eTRTxKuXF6Q</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F9784BF-4388-4AED-89B8-FB741C9FDBB9</gtr:id><gtr:title>Intracellular serpins, firewalls and tissue necrosis.</gtr:title><gtr:parentPublicationTitle>Trends in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b7c6bfc1bae97372046055e2e769195"><gtr:id>6b7c6bfc1bae97372046055e2e769195</gtr:id><gtr:otherNames>Marciniak SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0962-8924</gtr:issn><gtr:outcomeId>DC2C881CE3C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4AD34B05-9BE1-4629-B3A6-876FD4AB6F02</gtr:id><gtr:title>Paneth cells as a site of origin for intestinal inflammation.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba50e92374fab1a8fa28658b9102b4b2"><gtr:id>ba50e92374fab1a8fa28658b9102b4b2</gtr:id><gtr:otherNames>Adolph TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_12631_21_24089213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1ABC8DDC-3FFA-491B-B15E-C3C576439B06</gtr:id><gtr:title>A novel monoclonal antibody to characterize pathogenic polymers in liver disease associated with alpha1-antitrypsin deficiency.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef6499f68ace8d7e6a2eeae99a83daf6"><gtr:id>ef6499f68ace8d7e6a2eeae99a83daf6</gtr:id><gtr:otherNames>Miranda E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>ob6Gdbro5aQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52D4E041-B0F0-480D-9830-923AC81F547E</gtr:id><gtr:title>Polymers of Z a1-antitrypsin are secreted in cell models of disease.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec720d4c8a956c8e7c4038e910170a38"><gtr:id>ec720d4c8a956c8e7c4038e910170a38</gtr:id><gtr:otherNames>Fra A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn><gtr:outcomeId>58bd3c1f5f1266.54252837</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34640864-12C7-40ED-8976-3A1BF18BEACC</gtr:id><gtr:title>Characterising the association of latency with a(1)-antitrypsin polymerisation using a novel monoclonal antibody.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/455a84b93aefbf86b2bdcb87b72facd1"><gtr:id>455a84b93aefbf86b2bdcb87b72facd1</gtr:id><gtr:otherNames>Tan L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>5675dd5e7f181</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68F566E0-C389-4593-9119-17812FCB3DEB</gtr:id><gtr:title>Diabetes as a disease of endoplasmic reticulum stress.</gtr:title><gtr:parentPublicationTitle>Diabetes/metabolism research and reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ce2846dbc3dd405f1e8fe7efc22c044"><gtr:id>8ce2846dbc3dd405f1e8fe7efc22c044</gtr:id><gtr:otherNames>Thomas SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1520-7552</gtr:issn><gtr:outcomeId>FAWv9sqU3BR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>840242CC-CB5E-4AE8-8BAA-73103DFCFFC3</gtr:id><gtr:title>The TRiC/CCT chaperone is implicated in Alzheimer's disease based on patient GWAS and an RNAi screen in A?-expressing Caenorhabditis elegans.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36688dfd02cdf9038c075b02a278b29d"><gtr:id>36688dfd02cdf9038c075b02a278b29d</gtr:id><gtr:otherNames>Khabirova E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5419da708617d9.25158405</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B92BD3D-E2C5-471A-A1F3-D3CE8002822A</gtr:id><gtr:title>Recurrent pneumothorax.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17fabfb19208baac057b6f39cfa62200"><gtr:id>17fabfb19208baac057b6f39cfa62200</gtr:id><gtr:otherNames>Hopkins TG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>Ms92ZfQTtiZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34F147A9-B84D-4CCD-A316-7D3D9971AF6F</gtr:id><gtr:title>Phosphoproteins in stress-induced disease.</gtr:title><gtr:parentPublicationTitle>Progress in molecular biology and translational science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f1b61b7397511efbfc833269662f03a"><gtr:id>8f1b61b7397511efbfc833269662f03a</gtr:id><gtr:otherNames>Dalton LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1877-1173</gtr:issn><gtr:outcomeId>pm_12631_21_22340719</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADC67D36-7E25-462A-AA6E-B6BBA6408353</gtr:id><gtr:title>Endoplasmic reticulum-associated degradation (ERAD) and autophagy cooperate to degrade polymerogenic mutant serpins.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a275f6dc84f36fec5937aed4ea02da1"><gtr:id>0a275f6dc84f36fec5937aed4ea02da1</gtr:id><gtr:otherNames>Kroeger H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>5E9DCB63086</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD133DC0-DB62-431F-BF22-C601F41ABBC4</gtr:id><gtr:title>The endoplasmic reticulum remains functionally connected by vesicular transport after its fragmentation in cells expressing Z-a1-antitrypsin.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/430d8e459ce88909a545110552e678c5"><gtr:id>430d8e459ce88909a545110552e678c5</gtr:id><gtr:otherNames>Dickens JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>58bd3c1ec14265.75293128</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD94A188-AD2D-4C58-BA92-E3D6FD91835E</gtr:id><gtr:title>Impaired tissue growth is mediated by checkpoint kinase 1 (CHK1) in the integrated stress response.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0c027531dbd4f201d7cb44046a044ee"><gtr:id>f0c027531dbd4f201d7cb44046a044ee</gtr:id><gtr:otherNames>Malzer E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>dHrsaAJ2jt3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0FB471F-B9EB-43EF-826B-408B0CA27F74</gtr:id><gtr:title>Guidelines for the use and interpretation of assays for monitoring autophagy.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3338e204a3c58e1fab88cb3342a71645"><gtr:id>3338e204a3c58e1fab88cb3342a71645</gtr:id><gtr:otherNames>Klionsky DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>pm_12631_21_22966490</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E99F1A1A-B6B0-47FB-9034-F710C70E2DC3</gtr:id><gtr:title>Characterisation of serpin polymers in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>Methods (San Diego, Calif.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a12261156b163aa7165a4fc782edd347"><gtr:id>a12261156b163aa7165a4fc782edd347</gtr:id><gtr:otherNames>Belorgey D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1046-2023</gtr:issn><gtr:outcomeId>QnPFmPuQRdU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA4E44B5-EBD0-43DC-A2F3-2E832D023525</gtr:id><gtr:title>alpha1-Antitrypsin deficiency, chronic obstructive pulmonary disease and the serpinopathies.</gtr:title><gtr:parentPublicationTitle>Clinical science (London, England : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99363a5a0220904537f445b11858fb4e"><gtr:id>99363a5a0220904537f445b11858fb4e</gtr:id><gtr:otherNames>Ekeowa UI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0143-5221</gtr:issn><gtr:outcomeId>2E57FD8E5B7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E7134B1-87E8-4D03-BFE3-D09B987DDCC2</gtr:id><gtr:title>a1-Antitrypsin deficiency.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Disease primers</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/451f9355458a21582f41918901790b0e"><gtr:id>451f9355458a21582f41918901790b0e</gtr:id><gtr:otherNames>Greene CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2056-676X</gtr:issn><gtr:outcomeId>58bd3c1f347347.94438524</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51180B75-84AA-4021-8F07-CD81B98D957E</gtr:id><gtr:title>Neuroserpin polymers activate NF-kappaB by a calcium signaling pathway that is independent of the unfolded protein response.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/561dad709a0c7a519b602a4ab102ee03"><gtr:id>561dad709a0c7a519b602a4ab102ee03</gtr:id><gtr:otherNames>Davies MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>9A31F1C6B50</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>632F308D-CF9C-4F33-BF67-8158BC50CE8C</gtr:id><gtr:title>The serpinopathies studying serpin polymerization in vivo.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a97c91ca9350b38134a6403aba65587"><gtr:id>5a97c91ca9350b38134a6403aba65587</gtr:id><gtr:otherNames>Irving JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0076-6879</gtr:issn><gtr:outcomeId>pm_12631_21_22078544</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601840</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>